Literature DB >> 652037

Haloperidol-induced presynaptic dopamine supersensitivity is blocked by chronic lithium.

D W Gallager, A Pert, W E Bunney.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 652037     DOI: 10.1038/273309a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  17 in total

1.  Lithium and bupropion antagonise the phasic changes in locomotor activity caused by dopamine infused into the rat nucleus accumbens.

Authors:  J C Barnes; B Costall; A M Domeney; R J Naylor
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

Review 2.  Neuroendocrine markers of CNS drug effects.

Authors:  E C Johnstone; I N Ferrier
Journal:  Br J Clin Pharmacol       Date:  1980-07       Impact factor: 4.335

3.  Lithium dampens neurotransmitter response in smooth muscle: relevance to action in affective illness.

Authors:  H A Menkes; J M Baraban; A N Freed; S H Snyder
Journal:  Proc Natl Acad Sci U S A       Date:  1986-08       Impact factor: 11.205

4.  Effect of chronic lithium treatment with or without haloperidol on number and sizes of neurons in rat neocortex.

Authors:  R W Licht; J O Larsen; D Smith; H Braendgaard
Journal:  Psychopharmacology (Berl)       Date:  1994-07       Impact factor: 4.530

5.  Lithium does not interact with haloperidol in the dopaminergic pathways of the rat brain.

Authors:  A Reches; V Jackson-Lewis; S Fahn
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

6.  The effects of chronic lithium on behavioral and biochemical indices of dopamine receptor supersensitivity in the rat.

Authors:  K J Pittman; A Jakubovic; H C Fibiger
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

7.  Striatal dopamine and motor activity changes observed shortly after lithium administration.

Authors:  M E Otero Losada; M C Rubio
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1985-09       Impact factor: 3.000

8.  Failure of chronic lithium treatment to block tricyclic antidepressant-induced 5-HT supersensitivity.

Authors:  D W Gallager; W E Bunney
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1979-06       Impact factor: 3.000

9.  Tolerance to fluphenazine and supersensitivity to apomorphine in central dopaminergic systems after chronic fluphenazine decanoate treatment.

Authors:  S C Wheeler; R H Roth
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1980-06       Impact factor: 3.000

10.  Modulating role of lithium on dopamine turnover, prolactin release, and behavioral supersensitivity following haloperidol and reserpine.

Authors:  I M McIntyre; C Kuhn; S Demitriou; F R Fucek; M Stanley
Journal:  Psychopharmacology (Berl)       Date:  1983       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.